These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7021271)

  • 1. Waveform requirements for metabolic normalization with continuous intravenous insulin delivery in man.
    Perlman K; Ehrlich RM; Filler RM; Albisser AM
    Diabetes; 1981 Sep; 30(9):710-7. PubMed ID: 7021271
    [No Abstract]   [Full Text] [Related]  

  • 2. Temporal relationship of glycosylated haemoglobin concentrations to glucose control in diabetics.
    Dunn PJ; Cole RA; Soeldner JS; Gleason RE; Kwa E; Firoozabadi H; Younger D; Graham CA
    Diabetologia; 1979 Oct; 17(4):213-20. PubMed ID: 499681
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glycosylated hemoglobin in the metabolic control of diabetes mellitus].
    Almici C; Dughi S; Rigosa C
    Minerva Med; 1981 May; 72(20):1295-300. PubMed ID: 7243020
    [No Abstract]   [Full Text] [Related]  

  • 4. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycosylated hemoglobin HbA1c as an indicator of metabolic compensation in children with diabetes mellitus].
    Michalková D; Carský J; Bircák J; Kolár J; Baciaková L; Vitková M; Zmeková E
    Cesk Pediatr; 1981 May; 36(5):243-7. PubMed ID: 7261146
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycosylated hemoglobin in diabetes mellitus: correlations with fasting plasma glucose, serum lipids, and glycosuria.
    Aleyassine H; Gardiner RJ; Tonks DB; Koch P
    Diabetes Care; 1980; 3(4):508-14. PubMed ID: 7006944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps.
    Pietri A; Ehle AL; Raskin P
    Diabetes; 1980 Aug; 29(8):668-71. PubMed ID: 7002680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin a1c values in children with overt diabetes maintained in varying degrees of control.
    Jackson RL; Hess RL; England JD
    Diabetes Care; 1979; 2(5):391-5. PubMed ID: 510136
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic control. Self control of urinary and blood glucose and measurement of glycosylated hemoglobin (HbA1)].
    Hanssen KF; Dahl-Jørgensen K; Abyholm AS
    Tidsskr Nor Laegeforen; 1981 May; 101(13):780-4. PubMed ID: 7268712
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-controlled portable insulin infusion pump in diabetics.
    Bojsen J; Deckert T; Kølendorf K; Lørup B
    Diabetes; 1979 Nov; 28(11):974-9. PubMed ID: 488546
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycosylated hemoglobin: a tool in identifying psychological problems?
    Citrin W; Ellis GJ; Skyler JS
    Diabetes Care; 1980; 3(4):563-4. PubMed ID: 7460728
    [No Abstract]   [Full Text] [Related]  

  • 13. Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system.
    Gertner JM; Tamborlane WV; Horst RL; Sherwin RS; Felig P; Genel M
    J Clin Endocrinol Metab; 1980 May; 50(5):862-6. PubMed ID: 6246134
    [No Abstract]   [Full Text] [Related]  

  • 14. Portable insulin infusion systems in juvenile-onset diabetes.
    Tamborlane WV
    Hosp Pract; 1980 Oct; 15(10):91-9. PubMed ID: 6998857
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycosylated haemoglobin, blood glucose and serum cholesterol levels in diabetics treated with guar gum.
    Rosman MS
    S Afr Med J; 1981 May; 59(21):739-40. PubMed ID: 7233285
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy.
    Christiansen JS; Svendsen PA; Mathiesen E; Rubin P; Deckert T
    Horm Metab Res; 1981 Oct; 13(10):537-41. PubMed ID: 7028586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
    Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Sandvik L; Aagenaes O
    Br Med J (Clin Res Ed); 1985 Mar; 290(6471):811-5. PubMed ID: 3919804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoglobin AIc concentrations after initial insulin treatment for newly discovered diabetes.
    Ditzel J; Kjaergaard JJ
    Br Med J; 1978 Mar; 1(6115):741-2. PubMed ID: 630325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term control of brittle diabetes using a Biostator.
    Connor H; Atkin G; Attwood E
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1316-7. PubMed ID: 6812693
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycosylated haemoglobin levels in children with diabetes mellitus.
    Williams ML; Savage DC
    Arch Dis Child; 1979 Apr; 54(4):295-8. PubMed ID: 453913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.